321 related articles for article (PubMed ID: 38054579)
1. Population-level effectiveness of pre-exposure prophylaxis for HIV prevention among men who have sex with men in Montréal (Canada): a modelling study of surveillance and survey data.
Doyle CM; Milwid RM; Cox J; Xia Y; Lambert G; Tremblay C; Otis J; Boily MC; Baril JG; Thomas R; Blais AD; Trottier B; Grace D; Moore DM; Mishra S; Maheu-Giroux M
J Int AIDS Soc; 2023 Dec; 26(12):e26194. PubMed ID: 38054579
[TBL] [Abstract][Full Text] [Related]
2. Population-level impact of expanding PrEP coverage by offering long-acting injectable PrEP to MSM in three high-resource settings: a model comparison analysis.
Stansfield SE; Heitner J; Mitchell KM; Doyle CM; Milwid RM; Moore M; Donnell DJ; Hanscom B; Xia Y; Maheu-Giroux M; Vijver DV; Wang H; Barnabas R; Boily MC; Dimitrov DT
J Int AIDS Soc; 2023 Jul; 26 Suppl 2(Suppl 2):e26109. PubMed ID: 37439080
[TBL] [Abstract][Full Text] [Related]
3. Measuring progress towards reaching zero new HIV acquisitions among key populations in Québec (Canada) using routine surveillance data: a mathematical modelling study.
Doyle CM; Cox J; Milwid RM; Bitera R; Delaunay CL; Alary M; Lambert G; Tremblay C; Mishra S; Maheu-Giroux M
J Int AIDS Soc; 2022 Sep; 25(9):e25994. PubMed ID: 36050916
[TBL] [Abstract][Full Text] [Related]
4. Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand.
Suraratdecha C; Stuart RM; Manopaiboon C; Green D; Lertpiriyasuwat C; Wilson DP; Pavaputanon P; Visavakum P; Monkongdee P; Khawcharoenporn T; Tharee P; Kittinunvorakoon C; Martin M
J Int AIDS Soc; 2018 Jul; 21 Suppl 5(Suppl Suppl 5):e25129. PubMed ID: 30033559
[TBL] [Abstract][Full Text] [Related]
5. Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study.
Kasaie P; Schumacher CM; Jennings JM; Berry SA; Tuddenham SA; Shah MS; Rosenberg ES; Hoover KW; Gift TL; Chesson H; German D; Dowdy DW
BMJ Open; 2019 Mar; 9(3):e023453. PubMed ID: 30837248
[TBL] [Abstract][Full Text] [Related]
6. Improving the impact of HIV pre-exposure prophylaxis implementation in small urban centers among men who have sex with men: An agent-based modelling study.
Gantenberg JR; King M; Montgomery MC; Galárraga O; Prosperi M; Chan PA; Marshall BDL
PLoS One; 2018; 13(7):e0199915. PubMed ID: 29985949
[TBL] [Abstract][Full Text] [Related]
7. Estimating the potential impact of COVID-19-related disruptions on HIV incidence and mortality among men who have sex with men in the United States: a modelling study.
Mitchell KM; Dimitrov D; Silhol R; Geidelberg L; Moore M; Liu A; Beyrer C; Mayer KH; Baral S; Boily MC
medRxiv; 2020 Nov; ():. PubMed ID: 33173893
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a pre-exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens.
Ramautarsing RA; Meksena R; Sungsing T; Chinbunchorn T; Sangprasert T; Fungfoosri O; Meekrua D; Sumalu S; Pasansai T; Bunainso W; Wongsri T; Mainoy N; Colby D; Avery M; Mills S; Vannakit R; Phanuphak P; Phanuphak N
J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25540. PubMed ID: 32602660
[TBL] [Abstract][Full Text] [Related]
9. Modeling the potential impact of pre-exposure prophylaxis for HIV among men who have sex with men in Cameroon.
Lyons CE; Stokes-Cawley OJ; Simkin A; Bowring AL; Mfochive Njindam I; Njoya O; Bissek AZ; Tamoufe U; Georges S; Kakanou FZ; Turpin G; Levitt D; Billong SC; Mishra S; Baral S
BMC Infect Dis; 2022 Sep; 22(1):751. PubMed ID: 36163000
[TBL] [Abstract][Full Text] [Related]
10. High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis.
Hoornenborg E; Coyer L; Boyd A; Achterbergh RCA; Schim van der Loeff MF; Bruisten S; de Vries HJC; Koopsen J; van de Laar TJW; Prins M;
J Hepatol; 2020 May; 72(5):855-864. PubMed ID: 31862485
[TBL] [Abstract][Full Text] [Related]
11. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States.
Reisner SL; Moore CS; Asquith A; Pardee DJ; Sarvet A; Mayer G; Mayer KH
J Int AIDS Soc; 2019 Sep; 22(9):e25391. PubMed ID: 31536171
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness and impact of pre-exposure prophylaxis to prevent HIV among men who have sex with men in Asia: A modelling study.
Ten Brink DC; Martin-Hughes R; Minnery ME; Osborne AJ; Schmidt HA; Dalal S; Green KE; Ramaurtarsing R; Wilson DP; Kelly SL
PLoS One; 2022; 17(5):e0268240. PubMed ID: 35617169
[TBL] [Abstract][Full Text] [Related]
13. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
[TBL] [Abstract][Full Text] [Related]
14. Integrating HIV pre-exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study.
Bórquez A; Rich K; Farrell M; Degenhardt L; McKetin R; Tran LT; Cepeda J; Silva-Santisteban A; Konda K; Cáceres CF; Kelly S; Altice FL; Martin NK
J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25495. PubMed ID: 32562365
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and cost-effectiveness of early antiretroviral therapy and partners' pre-exposure prophylaxis among men who have sex with men in Shenyang, China: a prospective cohort and costing study.
Hu QH; Meyers K; Xu JJ; Chu ZX; Zhang J; Ding HB; Han XX; Jiang YJ; Geng WQ; Shang H
BMC Infect Dis; 2019 Jul; 19(1):663. PubMed ID: 31345169
[TBL] [Abstract][Full Text] [Related]
16. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.
Vuylsteke B; Reyniers T; De Baetselier I; Nöstlinger C; Crucitti T; Buyze J; Kenyon C; Wouters K; Laga M
J Int AIDS Soc; 2019 Oct; 22(10):e25407. PubMed ID: 31663257
[TBL] [Abstract][Full Text] [Related]
17. The potential effect of COVID-19-related disruptions on HIV incidence and HIV-related mortality among men who have sex with men in the USA: a modelling study.
Mitchell KM; Dimitrov D; Silhol R; Geidelberg L; Moore M; Liu A; Beyrer C; Mayer KH; Baral S; Boily MC
Lancet HIV; 2021 Apr; 8(4):e206-e215. PubMed ID: 33617783
[TBL] [Abstract][Full Text] [Related]
18. Can the combination of TasP and PrEP eliminate HIV among MSM in British Columbia, Canada?
Lima VD; Zhu J; Card KG; Lachowsky NJ; Chowell-Puente G; Wu Z; Montaner JSG
Epidemics; 2021 Jun; 35():100461. PubMed ID: 33984688
[TBL] [Abstract][Full Text] [Related]
19. Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study and cost-effectiveness analysis.
Zhao R; Fairley CK; Cook AR; Phanuphak N; He S; Tieosapjaroen W; Chow EPF; Phillips TR; Jin Tan RK; Wei Y; Shen M; Zhuang G; Ong JJ; Zhang L
Lancet Glob Health; 2024 Feb; 12(2):e243-e256. PubMed ID: 38245115
[TBL] [Abstract][Full Text] [Related]
20. Preference for using a variety of future HIV pre-exposure prophylaxis products among men who have sex with men in three US cities.
Mansergh G; Kota KK; Stephenson R; Hirshfield S; Sullivan P
J Int AIDS Soc; 2021 Jan; 24(1):e25664. PubMed ID: 33481359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
